Rankings
▼
Calendar
RAPT Q1 2023 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RAPT
RAPT Therapeutics, Inc.
$959M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$32M
Net Income
-$29M
EPS (Diluted)
$-6.12
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$248M
Total Liabilities
$28M
Stockholders' Equity
$220M
Cash & Equivalents
$46M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$641,000
-100.0%
Gross Profit
$0
$641,000
-100.0%
Operating Income
-$32M
-$21M
-51.9%
Net Income
-$29M
-$20M
-43.0%
← FY 2023
All Quarters
Q2 2023 →